{"sourcedb":"DevicePMAs@therightstef","sourceid":"P040003_S015","text":"Approval for changes to the indications for use statement, physician labeling, and patient labeling. the device, as modified, will be marketed under the trade name exablate magnetic resonance guided focused ultrasound system and is indicated to ablate uterine fibroid tissue in pre- or peri-menopausal women with symptomatic uterine fibroids who desire a uterine sparing procedure and whose uterine size is less than 24 weeks.","project":"consensus_PMA_Age_Indications"}